Targeted Clinical Development
The following is a listing of all applications reviewed under this RFA. Applications include the score (between 0 and 100, with 100 being the best) and a funding recommendation (indicated by the color key below) made by the Grants Working Group (GWG). A link to the Public Abstract (provided by applicant), Statement of Benefit to California (provided by applicant), and Public Review Report are available for each application by clicking on the application title.
|
|
= Recommended for funding |
|
= Not Recommended for funding at this time |
| Application Number | ICOC Decision | Title | Score |
|---|---|---|---|
| CT1-05168 | Approved | Evaluation of Safety and Preliminary Efficacy of Escalating Doses of GRNOPC1 in Subacute Spinal Cord Injury | 66 |
Current RFAs
CIRM funds grants through directed Requests for Applications (RFAs).
Workshop Reports
CIRM holds regular scientific workshops and meetings to update the scientific staff and CIRM grantees about particular areas of stem cell and related research.
Alpha Stem Cell Clinics: Delivering a New Kind of Medicine [pdf]
Cerebral Palsy Workshop Report [pdf]
Human iPS Cell Banking Workshop [pdf]
SCNT Workshop Report [pdf]
